The DOI matches its Crossref record; 81 of the 83 references it cites were found in a registry or an index.
Role of the aryl hydrocarbon receptor in cell cycle regulation
Abstract
Traditionally, the aryl hydrocarbon receptor (AHR) is considered to be a ligand-activated receptor and transcription factor responsible for the induction of drug-metabolizing enzymes. Its role in the combinatorial matrix of cell functions was neatly established long before the first report of an AHR cDNA sequence was published. Only recently, other functions of this protein have begun to be recognized. This review addresses novel findings relating to AHR functions that have resulted from experimental approaches markedly outside traditional receptor analyses. Here we examine the aspects of AHR biology relevant to its role in cell cycle regulation, from the activation of mitogen-activated protein kinases to the cross-talk between AHR and the RAS pathway and the functional significance of the interaction between AHR and the retinoblastoma protein. We have attempted to provide the reader with a balanced interpretation of the evidence, highlighting areas of consensus as well as areas still being contested.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the 15 fixed protein-coding changes identified here but absent from previous analyses1,20, some might have also contributed to complex modifications of pathways in cell division, like AHR65 or DNHD166 (Supplementary Information 1), as well as other genes with HHMCs, like CHEK167 or the gene encoding for the protein TOP2A68, which shows the largest number of interactions with other HHMC-carry”
From A catalog of single nucleotide changes distinguishing modern humans from archaic hominins (2019) · cites this paper as [65]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142
Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems
Kohn, K. W. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.8.2703 · Cited by 561
Induction of c‐fos expression through JNK‐mediated TCF/Elk‐1 phosphorylation.
Cavigelli, M., Dolfi, F., Claret, F. X., & Karin, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00284.x · Cited by 530
Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases
Zarkowska, T., & Mittnacht, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12738 · Cited by 494
Mechanism of active transcriptional repression by the retinoblastoma protein
Weintraub, S. J., Chow, K. N. B., Luo, R. X., Zhang, S. H., He, S., & Dean, D. C. (1995) · Nature · doi:10.1038/375812a0 · Cited by 487
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 406
Kolluri, S. K., Weiss, C., Koff, A., & Göttlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364
Checking out the G2/M transition
Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 359
Research works printed but not linked: 2
- A. Puga, J. Bohm, A. Hoffer, G.D. Leikauf, H.G. Shertzer, S. Zhou, Dioxin alters calcium homeostasis and the regulation of arachidonate metabolism in mouse hepatoma cells, Proceedings of the 15th International Symposium on Chlorinated Dioxins, vol. 25, 1995, pp. 381–386.
- Reiners, 1997, Downregulation of aryl hydrocarbon receptor function and cytochrome P450 1A1 induction by expression of Ha-ras oncogenes, Mol. Carcinog., 19, 91, 10.1002/(SICI)1098-2744(199707)19:2<91::AID-MC4>3.0.CO;2-O · DOI
Cited by
Sorted by citations
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3846 · Cited by 916
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways
Puga, A., Ma, C., & Marlowe, J. L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.031 · Cited by 409
Self-citationAh receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions
Bock, K. W., & Köhle, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.017 · Cited by 340
Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis
Marlowe, J. L., & Puga, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20656 · Cited by 327
Self-citationMolecular mechanisms of AhR functions in the regulation of cytochrome P450 genes
Fujii-Kuriyama, Y., & Mimura, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.162 · Cited by 290
Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
Safe, S. H., Lee, S., & Jin, U.-H. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft128 · Cited by 281
Okey, A. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm096 · Cited by 264
Pocar, P., Fischer, B., Klonisch, T. C., & Hombach‐Klonisch, S. (2005) · Reproduction · doi:10.1530/rep.1.00294 · Cited by 197
Hahn, M. E., Allan, L. L., & Sherr, D. H. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.016 · Cited by 190
Regulating the regulator: Factors that control levels and activity of the aryl hydrocarbon receptor
Harper, P. A., Riddick, D. S., & Okey, A. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.007 · Cited by 160
Role of the aryl hydrocarbon receptor in drug metabolism
Ramadoss, P., Marcus, C. B., & Perdew, G. H. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.9 · Cited by 147
The Aryl Hydrocarbon Receptor Binds to E2F1 and Inhibits E2F1-induced Apoptosis
Marlowe, J. L., Fan, Y., Chang, X., Peng, L. H., Knudsen, E. S., Xia, Y., & Puga, A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0359 · Cited by 132
Self-citationFujii‐Kuriyama, Y., & Kawajiri, K. (2010) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.86.40 · Cited by 135
The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
O'Donnell, E. F., Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013128 · Cited by 124
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis
Schlezinger, J. J., Liu, D., Farago, M., Seldin, D. C., Belguise, K., Sonenshein, G. E., & Sherr, D. H. (2006) · Biological Chemistry · doi:10.1515/bc.2006.145 · Cited by 122
Adverse Health Effects in Humans Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)
Pelclová, D., Urban, P., Preiss, J., Lukáš, E., Fenclová, Z., Navrátil, T., Dubská, Z., & Šenholdová, Z. (2006) · Reviews on Environmental Health · doi:10.1515/reveh.2006.21.2.119 · Cited by 124
Duarte, J. H., Meglio, P. D., Hirota, K., Ahlfors, H., & Stockinger, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079819 · Cited by 127
Microarray analysis of the AHR system: Tissue-specific flexibility in signal and target genes
Frericks, M., Meissner, M., & Esser, C. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.01.014 · Cited by 124
Williamson, M. A. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi031 · Cited by 117
Uno, S. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.014 · Cited by 116
Analysis of zebrafish cyp19 promoters
Tong, S., & Chung, B. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00347-9 · Cited by 111
A catalog of single nucleotide changes distinguishing modern humans from archaic hominins
Kuhlwilm, M., & Boeckx, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-44877-x · Cited by 108
How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression
Wang, Z., Snyder, M., Kenison, J. E., Yang, K., Lara, B., Lydell, E., Bennani, K., Novikov, O., Federico, A. N., Monti, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010387 · Cited by 120
Nagayoshi, H., Kakimoto, K., Takagi, S., Konishi, Y., Kajimura, K., & Matsuda, T. (2014) · Environmental Science & Technology · doi:10.1021/es503926w · Cited by 109
Medjakovic, S., & Jungbauer, A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.001 · Cited by 103
Chang, X., Fan, Y., Karyala, S. V., Schwemberger, S. J., Tomlinson, C. R., Sartor, M. A., & Puga, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00323-07 · Cited by 106
Self-citationDioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting
Boutros, P. C., Moffat, I. D., Franc, M. A., Tijet, N., Tuomisto, J., Pohjanvirta, R., & Okey, A. B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.177 · Cited by 101
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond
Opitz, C. A., Holfelder, P., Prentzell, M. T., & Trump, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115798 · Cited by 108
Mulero‐Navarro, S., Pozo‐Guisado, E., Pérez-Mancera, P. A., Alvarez, A. M., Catalina‐Fernández, I., Hernández‐Nieto, E., Sáenz‐Santamaría, J., Martínez, N., Rojas, J. M., Sánchez-Garcı́a, I., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504538200 · Cited by 100
Chen, W.-C., Chang, L.-H., Huang, S.-S., Huang, Y., Chih, C.-L., Kuo, H., Lee, Y., & Lee, I. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1572-7 · Cited by 101
Ogiso, H., Kagi, N., Matsumoto, E., Nishimoto, M., Arai, R., Shirouzu, M., Mimura, J., Fujii-Kuriyama, Y., & Yokoyama, S. (2004) · Biochemistry · doi:10.1021/bi048736m · Cited by 91
Barnes, S., Knudsen, K. E., & Puga, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000356 · Cited by 94
Self-citationThe arylhydrocarbon receptor repressor (AhRR): structure, expression, and function
Haarmann‐Stemmann, T., & Abel, J. (2006) · Biological Chemistry · doi:10.1515/bc.2006.147 · Cited by 91
Yang, X., Liu, D., Murray, T. J., Mitchell, G. C., Hestermann, E. V., Karchner, S. I., Merson, R. R., Hahn, M. E., & Sherr, D. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208938 · Cited by 86
Vásquez, A. A., Atallah‐Yunes, N., Smith, F. C., You, X., Chase, S. E., Silverstone, A. E., & Vikstrom, K. L. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:2:153 · Cited by 84
Andrysík, Z., Vondráček, J., Machala, M., Krčmář, P., Sindlerova, L. S., Kranz, A., Weiß, C., Faust, D., Kozubı́k, A., & Dietrich, C. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.10.004 · Cited by 83
Ahmed, S., Valen, E., Sandelin, A., & Matthews, J. B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp144 · Cited by 83
Murray, T. J., Yang, X., & Sherr, D. H. (2006) · Breast Cancer Research · doi:10.1186/bcr1391 · Cited by 81
Agudo‐Barriuso, M., Pérez-Marín, M. C., Sobrado‐Calvo, P., ̈nngren, U. L., Salinas‐Navarro, M., Cánovas, I., Nadal-Nicolás, F. M., Miralles-Imperial, J., Hallböök, F., & Vidal‐Sanz, M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2404 · Cited by 81
The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells
O’Donnell, E. F., Kopparapu, P., Koch, D. C., Jang, H. S., Phillips, J. L., Tanguay, R. L., Kerkvliet, N. I., & Kolluri, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040926 · Cited by 81
The aryl hydrocarbon receptor and light
Rannug, A., & Fritsche, E. (2006) · Biological Chemistry · doi:10.1515/bc.2006.143 · Cited by 80
MacPherson, L., & Matthews, J. B. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.08.010 · Cited by 80
Goedtke, L., Sprenger, H., Hofmann, U., Schmidt, F. F., Hammer, H., Zanger, U. M., Poetz, O., Seidel, A., Braeuning, A., & Hessel‐Pras, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010372 · Cited by 78
Collins, L. L., Williamson, M. A., Thompson, B. D., Dever, D. P., Gasiewicz, T. A., & Opanashuk, L. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn017 · Cited by 76
TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents
Pääjärvi, G., Viluksela, M., Pohjanvirta, R., Stenius, U., & Högberg, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh289 · Cited by 74
Brauze, D., Widerak, M., Cwykiel, J. M., Szyfter, K., & Baer‐Dubowska, W. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.09.010 · Cited by 73
Chramostová, K., Vondráček, J., Sindlerova, L. S., Vojtěšek, B., Kozubı́k, A., & Machala, M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.008 · Cited by 69
Role of mitogen-activated protein kinases in aryl hydrocarbon receptor signaling
Henklová, P., Vrzal, R., Ulrichová, J., & Dvořák, Z. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.12.005 · Cited by 67
Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGFβ
Carvajal-González, J. M., Román, Á., Cerezo-Guisado, M. I., Rico-Leo, E. M., Martín‐Partido, G., & Fernández‐Salguero, P. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.047274 · Cited by 67
Induction of Oxidative Stress Responses by Dioxin and other Ligands of the Aryl Hydrocarbon Receptor
Reichard, J. F., Dalton, T. P., Shertzer, H. G., & Puga, A. (2005) · Dose-Response · doi:10.2203/dose-response.003.03.003 · Cited by 65
Self-citationActivation of the aryl hydrocarbon receptor by TCDD inhibits senescence: A tumor promoting event?
Ray, S. S., & Swanson, H. I. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.022 · Cited by 62
Hansen, D. A., Esakky, P., Drury, A. M., Lamb, L. E., & Moley, K. H. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.108845 · Cited by 62
The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
Gargaro, M., Scalisi, G., Manni, G., Mondanelli, G., Grohmann, U., & Fallarino, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020757 · Cited by 63
Kashuba, E., Gradin, K., Isaguliants, M., Székely, L., Poellinger, L., Klein, G., & Kazlauskas, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509036200 · Cited by 60
Cheon, H. J., Woo, Y.-S., Lee, J. Y., Kim, H. S., Kim, H. J., Cho, S., Won, N. H., & Sohn, J. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.58 · Cited by 59
Lavine, J. A., Rowatt, A. J., Klimova, T., Whitington, A. J., Dengler, E., Beck, C., & Powell, W. H. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi228 · Cited by 57
Tiong, C. T., Chen, C., Zhang, S. J., Li, J., Soshilov, A. A., Denison, M. S., Lee, L., Tam, V. H., Wong, S. P., Xu, H. E., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs110 · Cited by 54
Salminen, A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04520-x · Cited by 58
Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells
Tanaka, G., Kanaji, S., Hirano, A., Arima, K., Shinagawa, A., Goda, C., Yasunaga, S., Ikizawa, K., Yanagihara, Y., Kubo, M., et al. (2005) · International Immunology · doi:10.1093/intimm/dxh260 · Cited by 55
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis
Ochieng, J., Nangami, G. N., Ogunkua, O., Miousse, I. R., Koturbash, I., Odero-Marah, V., McCawley, L. J., Nangia‐Makker, P., Ahmed, N., Luqmani, Y., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv034 · Cited by 54
Nakatsuru, Y., Wakabayashi, K., Fujii‐Kuriyama, Y., Ishikawa, T., Kusama, K., & Ide, F. (2004) · International Journal of Cancer · doi:10.1002/ijc.20365 · Cited by 53
Vondráček, J. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi009 · Cited by 52
Sovadinová, I., Bláha, L., Janošek, J., Hilscherová, K., Giesy, J. P., Jones, P. D., & Holoubek, I. (2006) · Environmental Toxicology and Chemistry · doi:10.1897/05-388r.1 · Cited by 51
Vrzal, R., Jitka Ulrichová, A., & Dvořák, Z. (2004) · Biomedical Papers · doi:10.5507/bp.2004.001 · Cited by 51
Yang, S. Y. C., Ahmed, S., Satheesh, S. V., & Matthews, J. B. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2022-x · Cited by 49
Koch, D. C., Jang, H. S., O’Donnell, E. F., Punj, S., Kopparapu, P., Bisson, W. H., Kerkvliet, N. I., & Kolluri, S. K. (2015) · Oncogene · doi:10.1038/onc.2015.55 · Cited by 51
The Aryl Hydrocarbon Receptor Pathway and Sexual Differentiation of Neuroendocrine Functions
Petersen, S. L., Krishnan, S., & Hudgens, E. D. (2006) · Endocrinology · doi:10.1210/en.2005-1157 · Cited by 50
Nault, R., Fader, K. A., Kirby, M. P., Ahmed, S., Matthews, J. B., Jones, A. D., Lunt, S. Y., & Zacharewski, T. R. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv245 · Cited by 51
The aryl hydrocarbon receptor at the crossroads of multiple signaling pathways.
Ma, C., Marlowe, J., & Puga, A. (2009) · EXS · doi:10.1007/978-3-7643-8336-7_9 · Cited by 48
Self-citationLiu, D., Pan, L., Cai, Y., Li, Z., & Miao, J. (2014) · Environmental Pollution · doi:10.1016/j.envpol.2014.02.013 · Cited by 46
Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma
Ng, C., Janoo-Gilani, R., Sipahimalani, P., Gallagher, R. P., Gascoyne, R. D., Connors, J. M., Weber, J., Lai, A. S., Leach, S. R., Le, N. D., et al. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9429-5 · Cited by 47
TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident
Landi, M. T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg002 · Cited by 46
Mechanistic features of recombination in HIV.
Galetto, R., & Negroni, M. (2005) · PubMed · Cited by 45
Latchney, S. E., Lioy, D. T., Henry, E. C., Gasiewicz, T. A., Strathmann, F. G., Mayer‐Pröschel, M., & Opanashuk, L. A. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0529 · Cited by 51
Cirillo, F., Lappano, R., Bruno, L., Rizzuti, B., Grande, F., Guzzi, R., Briguori, S., Miglietta, A., Nakajima, M., Martino, M. T. D., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1337-2 · Cited by 48
Kalmes, M., Hennen, J., Clemens, J., & Blömeke, B. (2011) · Biological Chemistry · doi:10.1515/bc.2011.067 · Cited by 44
Madak‐Erdogan, Z., & Katzenellenbogen, B. S. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr300 · Cited by 47
Huang, C., Lee, C., Chang, K., Chang, W., Liu, Y.-W., Lee, J., & Chen, B. (2015) · Oncotarget · doi:10.18632/oncotarget.3448 · Cited by 43
Huang, X., Xu, X., Dai, Y., Cheng, Z., Zheng, X., & Huo, X. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138009 · Cited by 42
Nuclear receptors in the cross-talk of drug metabolism and inflammation
Gerbal‐Chaloin, S., Iankova, I., Maurel, P., & Daujat‐Chavanieu, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.756011 · Cited by 41
The Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells
Dever, D. P., & Opanashuk, L. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.077305 · Cited by 41
Vondráček, J., Sindlerova, L. S., Pěnčíková, K., Krčmář, P., Andrysík, Z., Chramostová, K., Marvanová, S., Valovičová, Z., Kozubı́k, A., Gábelová, A., et al. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.11.005 · Cited by 41
Aryl hydrocarbon receptor (AhR) impairs circadian regulation: Impact on the aging process
Salminen, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101928 · Cited by 40
Cho, Y. C., Zheng, W., Yamamoto, M., Liu, X., Hanlon, P. R., & Jefcoate, C. R. E. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.04.025 · Cited by 38
Luckert, C., Hessel‐Pras, S., Lenze, D., & Lampen, A. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.06.021 · Cited by 37
Singhal, R., Shankar, K., Badger, T. M., & Ronis, M. J. J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm288 · Cited by 37
The p53 Inhibitor Pifithrin-α Is a Potent Agonist of the Aryl Hydrocarbon Receptor
Hoagland, M. S., Hoagland, E. M., & Swanson, H. I. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084186 · Cited by 40
Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer.
Zhang, H., Dong, Y., Zhao, H., Brooks, J. D., Hawthorn, L., Nowak, N. J., Marshall, J. R., Gao, A. C., & Ip, C. C. Y. (2005) · PubMed · Cited by 37
Funatake, C. J. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh245 · Cited by 36
FOXA1 Is Essential for Aryl Hydrocarbon Receptor–Dependent Regulation of Cyclin G2
Ahmed, S., Al-Saigh, S., & Matthews, J. B. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0502 · Cited by 34
Vuori, K. A. M., & Nikinmaa, M. (2007) · AMBIO · doi:10.1579/0044-7447(2007)36[168:msibsa]2.0.co;2 · Cited by 33
Aryl hydrocarbon receptor biology and xenobiotic responses in hematopoietic progenitor cells
Hirabayashi, Y., & Inoue, T. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.030 · Cited by 33
Portaz, A. C. D. T., Caimi, G. R., Sánchez, M., Chiappini, F., Randi, A. S., de Pisarev, D. L. K., & Álvarez, L. (2015) · Toxicology · doi:10.1016/j.tox.2015.07.013 · Cited by 31
Ji, C., Magnuson, J. T., Zhang, W., & Zhao, M. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.123893 · Cited by 31
Nault, R., Fader, K. A., Harkema, J. R., & Zacharewski, T. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184842 · Cited by 31
Guo, B., Xu, Z., Yan, X., Buttino, I., Li, J., Zhou, C., & Qi, P. (2020) · Frontiers in Marine Science · doi:10.3389/fmars.2020.00119 · Cited by 30
Insulin like growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7 breast cancer cells
Tomblin, J. K., & Salisbury, T. B. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.112 · Cited by 29
Yin, X., Chen, J., Mao, W., Wang, Y., & Chen, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2410 · Cited by 28
Metadata
- Authors
- Puga, A., Xia, Y., & Elferink, C.
- Affiliations
- University of Cincinnati Medical Center (US)
- The University of Texas Medical Branch at Galveston (US)
- Corresponding author
- Puga, Alvaro
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 141
- Issue
- 1-2
- Pages
- 117-130
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W2139905874
- Cited by
- 192
- References
- 83
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 5 · 2013: 10 · 2012: 11
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemico-Biological Interactions (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (R01ES007800, R01ES010807, ES10807, P30ES006096, R01 ES07800, R01ES006273, P30 ES-06096, R01 ES-06273)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- aryl hydrocarbon receptor, cell cycle regulation, mitogen-activated protein kinase, Ras signaling, retinoblastoma protein, signal transduction, transcription factors, drug-metabolizing enzymes
- MeSH terms
- Animals, Cell Cycle, Gene Expression Regulation, Phosphorylation, Xenobiotics, Signal Transduction, Oncogene Proteins, Genes, Tumor Suppressor, Receptors, Aryl Hydrocarbon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review